Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Glycyrrhiza uralensis honey
TCM honey-processed licorice with enhanced tonic and harmonizing properties; used to tonify qi and restore pulse.
Zhi Gan Cao (honey-processed Glycyrrhiza uralensis) is a traditional Chinese herb used to tonify heart qi, regulate pulse, and harmonize formula actions. Its key compounds—glycyrrhizin, liquiritin, isoliquiritin, and glycyrrhetic acid—contribute to antiarrhythmic, anti-inflammatory, and adrenal-supportive effects. Evidence level C indicates limited clinical data, primarily from small trials and traditional use.
Glycyrrhizin and its metabolite glycyrrhetic acid inhibit 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2), increasing cortisol availability and potentiating mineralocorticoid receptor activation, which can enhance sodium retention and potassium excretion. Liquiritin and isoliquiritin exhibit antiarrhythmic effects via modulation of cardiac ion channels (e.g., hERG, Nav1.5) and reduction of oxidative stress. The honey processing may alter bioavailability and reduce glycyrrhizin's adverse effects while enhancing demulcent and harmonizing properties.
TCM honey-processed licorice with enhanced tonic and harmonizing properties; used to tonify qi and restore pulse.
Zhi Gan Cao (honey-processed Glycyrrhiza uralensis) is a traditional Chinese herb used to tonify heart qi, regulate pulse, and harmonize formula actions. Its key compounds—glycyrrhizin, liquiritin, isoliquiritin, and glycyrrhetic acid—contribute to antiarrhythmic, anti-inflammatory, and adrenal-supportive effects. Evidence level C indicates limited clinical data, primarily from small trials and traditional use.
Glycyrrhizin and its metabolite glycyrrhetic acid inhibit 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2), increasing cortisol availability and potentiating mineralocorticoid receptor activation, which can enhance sodium retention and potassium excretion. Liquiritin and isoliquiritin exhibit antiarrhythmic effects via modulation of cardiac ion channels (e.g., hERG, Nav1.5) and reduction of oxidative stress. The honey processing may alter bioavailability and reduce glycyrrhizin's adverse effects while enhancing demulcent and harmonizing properties.